Search
for

    Glossary Creatine Kinase

    enzyme that helps produce energy in muscles

    Creatine Kinase (CK), also known as Creatine Phosphokinase (CPK), is an enzyme found in the heart, brain, and skeletal muscles. It plays a crucial role in energy production by catalyzing the conversion of creatine and adenosine triphosphate (ATP) into phosphocreatine and adenosine diphosphate (ADP). Elevated levels of CK in the blood can indicate muscle damage, heart attack, or other medical conditions affecting muscle tissue.

    Related Terms

    Sort by

    Research 30 of 1000+

    1. Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo Clinical and Experimental Dermatology · 2017 · 37 citations
    2. Cardioprotective effect of royal jelly on paclitaxel-induced cardio-toxicity in rats. PubMed · 2016 · 24 citations
    3. Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma Clinical Cancer Research · 2015 · 16 citations
    4. Biomarkers of selenium status in dogs BMC veterinary research · 2016 · 11 citations
    5. Finasteride-Induced Myalgia and HyperCKemia Journal of Clinical Neuromuscular Disease · 2008 · 10 citations
    6. A serious side effect of a potentially widely used cosmetic product Clinical and Experimental Dermatology · 2015 · 3 citations
    7. Comprehensive Case Analysis: Diagnosing and Managing Myositis in Newly Diagnosed Systemic Lupus Erythematosus Patients in Indonesia. PubMed · 2026
    8. Association of Anti-Signal Recognition Particle Myopathy with Systemic Lupus Erythematosus Neurology India · 2025
    9. Hoffman syndrome with the classic sign of myoedema and an unusual finding of systolic heart failure BMJ Case Reports · 2023
    10. BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience British Journal of Dermatology · 2023
    11. Preliminary data on biomarkers for selenium status in dogs 2015
    12. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2) American Journal of Clinical Dermatology · 2023 · 20 citations
    13. Baricitinib: A Review in Severe Alopecia Areata American Journal of Clinical Dermatology · 2023 · 1 citations
    14. Alopecia Areata, triggered by psychological stress and successfully treated with a Janus kinase inhibitor. Case report 2022
    15. Therapeutic Approaches for Alopecia Areata in Children Aged 6 to 11 Years Cutis · 2025
    16. <i>In Vitro</i> and <i>In Vivo</i> Models for the Development of Hair Growth Materials By Regulating the <i>β</i>-Catenin Signaling Pathways Journal of medicinal food · 2024
    17. Use of Rituximab for Dermatomyositis Over Conventional Therapy: A Case Report Case Reports in Rheumatology · 2026
    18. Non-small cell lung carcinoma spheroid models in agarose microwells for drug response studies Lab on a Chip · 2022 · 45 citations
    19. Macrocytosis and pseudoalbinism: Manifestations of selenium deficiency The Journal of Pediatrics · 1987 · 126 citations
    20. Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA) in a 56-Year-Old Patient With Silicone Breast Implants: A Case Report Cureus · 2026
    21. Lower Extremity Cramping and Palpitations in a 17-Year-Old Boy Pediatrics in Review · 2026
    22. Comparative Study of Myocardial Biomarkers Among Women with and Without Polycystic Ovarian Syndrome (Pcos) in Nigeria International journal of research and scientific innovation · 2025
    23. Comprehensive Case Analysis: Diagnosing and Managing Myositis in Newly Diagnosed Systemic Lupus Erythematosus Patients in Indonesia SHILAP Revista de lepidopterología · 2026
    24. Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report Clinical Cosmetic and Investigational Dermatology · 2024
    25. Janus Kinase Inhibitors in the Treatment of Alopecia Areata Prague Medical Report · 2023 · 2 citations
    26. Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective Dermatology practical & conceptual · 2022 · 8 citations
    27. Efficacy of Janus kinase inhibitors in adult patients with alopecia areata International journal of research in dermatology · 2023
    28. Protein Kinase C<i>ε</i>, Which Is Linked to Ultraviolet Radiation-Induced Development of Squamous Cell Carcinomas, Stimulates Rapid Turnover of Adult Hair Follicle Stem Cells Journal of skin cancer · 2013 · 10 citations
    29. The Role of Janus Kinase Inhibitors in Dermatology Eduvest - Journal Of Universal Studies · 2026
    30. Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis Acta dermato-venereologica · 2023 · 10 citations